A meta-analysis of randomized controlled trials has found that catheter ablation was superior to conventional drug therapy alone for patients with atrial fibrillation (AFib) and heart failure.
AFib may lead to thromboembolic stroke, systemic embolism, and decompensated heart failure. Although catheter ablation is an established therapeutic strategy for AFib, guidelines recommend caution in certain patients, and the benefits and harms of catheter ablation versus drug therapy for Afib patients have not been firmly established.
Get the full story on our sister site, Medical Design & Outsourcing.
The post Study: Catheter ablation better for AFib, heart failure than drugs appeared first on MassDevice.
from MassDevice http://bit.ly/2VaCx0X
Cap comentari:
Publica un comentari a l'entrada